ATE247162T1 - Selbstinduzierer - Google Patents

Selbstinduzierer

Info

Publication number
ATE247162T1
ATE247162T1 AT92908821T AT92908821T ATE247162T1 AT E247162 T1 ATE247162 T1 AT E247162T1 AT 92908821 T AT92908821 T AT 92908821T AT 92908821 T AT92908821 T AT 92908821T AT E247162 T1 ATE247162 T1 AT E247162T1
Authority
AT
Austria
Prior art keywords
pct
date oct
sec
compound
gene expression
Prior art date
Application number
AT92908821T
Other languages
English (en)
Inventor
Barrie Walsham Bycroft
Paul Williams
Gordon Sidney Anderson Stewart
Siri Ram Chhabra
Paul Stead
Michael Kenneth Winson
Philip John Hill
Catherine Elizabeth Dunn Rees
Nigel John Bainton
Original Assignee
Univ Nottingham
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Nottingham filed Critical Univ Nottingham
Application granted granted Critical
Publication of ATE247162T1 publication Critical patent/ATE247162T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/38—Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Plant Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Indole Compounds (AREA)
  • Liquid Developers In Electrophotography (AREA)
  • Control Of Eletrric Generators (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT92908821T 1991-04-18 1992-04-16 Selbstinduzierer ATE247162T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919108307A GB9108307D0 (en) 1991-04-18 1991-04-18 Autoinducer
PCT/GB1992/000713 WO1992018614A1 (en) 1991-04-18 1992-04-16 Autoinducer

Publications (1)

Publication Number Publication Date
ATE247162T1 true ATE247162T1 (de) 2003-08-15

Family

ID=10693505

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92908821T ATE247162T1 (de) 1991-04-18 1992-04-16 Selbstinduzierer

Country Status (10)

Country Link
US (1) US5593827A (de)
EP (1) EP0580692B1 (de)
JP (1) JPH06506588A (de)
AT (1) ATE247162T1 (de)
CA (1) CA2105395A1 (de)
DE (1) DE69233160T2 (de)
DK (1) DK0580692T3 (de)
ES (1) ES2203610T3 (de)
GB (1) GB9108307D0 (de)
WO (1) WO1992018614A1 (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995001175A1 (en) * 1993-07-02 1995-01-12 The University Of Nottingham Immunosuppressant and antiallergic compounds, e.g. n-(3-oxohexanoyl) homoserine lactone
US6936447B1 (en) 2000-04-03 2005-08-30 University Of Iowa Research Foundation Autoinducer molecule
US5591872A (en) * 1993-08-09 1997-01-07 The University Of Iowa Research Foundation Autoinducer molecule
US5759798A (en) * 1995-12-08 1998-06-02 Woods Hole Oceanographic Institution Assays, test kits and bacteria for detection of autoinducers
US6455031B1 (en) 1997-06-18 2002-09-24 David G Davies Methods and compositions for controlling biofilm development
ATE342661T1 (de) * 1997-06-18 2006-11-15 Univ Montana State Homoserinlactone zum regulieren von biofilmen und methoden zur anwendung
GB9725599D0 (en) * 1997-12-04 1998-02-04 Univ Nottingham Control of biofilm formation
US6395282B1 (en) 1998-04-16 2002-05-28 University Of Rochester Immunogenic conjugates of Gram-negative bacterial autoinducer molecules
US6337347B1 (en) * 1998-06-18 2002-01-08 The Research & Development Institute, Inc. Autoinducer compounds
US6756404B2 (en) 1998-06-18 2004-06-29 The Research & Development Institute, Inc. Autoinducer compounds
US6720415B2 (en) 1998-12-02 2004-04-13 Princeton University Compositions and methods for regulating bacterial pathogenesis
AU1933800A (en) * 1998-12-02 2000-06-19 Princeton University Compositions and methods for regulating bacterial pathogenesis
US7326542B2 (en) * 1998-12-02 2008-02-05 Princeton University Compositions and methods for regulating bacterial pathogenesis
DK1190079T3 (da) 1999-07-01 2006-10-09 Calgene Llc Regulering af genekspression i eukaryote celler
EP1507010B1 (de) * 1999-07-01 2009-08-12 Calgene LLC Kontrolle der Genexpression in eukaryotischen Zellen
WO2001018248A2 (en) 1999-09-03 2001-03-15 The University Of Iowa Research Foundation Quorum sensing signaling in bacteria
GB9924195D0 (en) 1999-10-13 1999-12-15 Univ Nottingham N-Acyl homoserine lactones for the treatment of cardiac tachyarrhythmias Ischaemic heart disease or congestive heart failure
GB0007588D0 (en) * 2000-03-30 2000-05-17 Univ Nottingham N-Acyl homoserine lactones
WO2001085664A2 (en) 2000-05-10 2001-11-15 Princeton University Compounds and methods for regulating bacterial growth and pathogenesis
US20030023032A1 (en) * 2000-05-10 2003-01-30 Bassler Bonnie L. LuxO-sigma54 interactions and methods of use
US6703513B1 (en) 2000-06-02 2004-03-09 K-Quay Enterprises Llc Production and use of derivatized homoserine lactones
WO2002018342A2 (en) * 2000-08-31 2002-03-07 The University Of Iowa Research Foundation Novel autoinducer molecules and uses therefor
AU2002219348B2 (en) 2001-01-08 2006-11-16 Pathway Intermediates Ltd Autoinducer compounds and their uses
WO2002094188A2 (en) * 2001-05-21 2002-11-28 Quorex Pharmaceuticals, Inc. Methods for regulating bacteria
GB0122026D0 (en) * 2001-09-12 2001-10-31 Univ Nottingham Insulitis
DE10219031A1 (de) * 2002-04-29 2003-11-20 Bayer Ag Verfahren und Vorrichtung zum Nachweis biologisch aktiver Substanzen
EP1359226B1 (de) 2002-04-29 2006-11-22 Bayer Innovation GmbH Verfahren und Vorrichtung zum Nachweis biologisch aktiver Substanzen
GB2418427A (en) 2004-09-02 2006-03-29 Univ Cambridge Tech Ligands for G-protein coupled receptors
CA2596480A1 (en) * 2005-02-04 2006-08-10 Wisconsin Alumni Research Foundation Compounds and methods for modulating communication and virulence in quorum sensing bacteria
GB0512238D0 (en) * 2005-06-15 2005-07-27 Univ Cambridge Tech Anti-inflammatory agents
GB0610042D0 (en) * 2006-05-22 2006-06-28 Univ Nottingham Substituted n-acyl homoserine lactones
EP2136800A4 (de) 2007-03-19 2011-10-05 Wisconsin Alumni Res Found Modulation der bakteriellen quorum-messung mit synthetischen liganden
US7662967B2 (en) 2007-08-02 2010-02-16 Cambridge Enterprise Limited Anti-inflammatory compounds and compositions
GB2452696B (en) * 2007-08-02 2009-09-23 Cambridge Entpr Ltd 3-(2',2'-dimethylpropanoylamino)-tetrahydropyridin-2-one and its use in pharmaceutical compositions
US8663927B2 (en) * 2007-09-10 2014-03-04 University Of Kentucky Research Foundation Systems and methods for diagnosis and monitoring of bacteria-related conditions
WO2010150691A1 (ja) * 2009-06-22 2010-12-29 住友重機械工業株式会社 アンモニア態窒素含有排水処理方法
US8624063B2 (en) 2009-06-30 2014-01-07 Wisconsin Alumni Research Foundation Non-lactone carbocyclic and heterocyclic antagonists and agonists of bacterial quorum sensing
WO2011153502A2 (en) * 2010-06-04 2011-12-08 The Regents Of The University Of California Anti-inflammatory and quorum sensing inhibition compounds and methods of making and using them
JP5579523B2 (ja) * 2010-07-23 2014-08-27 国立大学法人 東京大学 創傷治療のための医薬
CN106146378B (zh) * 2015-03-23 2018-09-18 兰州大学 一种酰化高丝氨酸内酯类化合物及其环保应用
US10526278B2 (en) 2017-10-19 2020-01-07 Wisconsin Alumni Research Foundation Inhibitors of quorum sensing receptor LasR

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4861709A (en) * 1985-05-31 1989-08-29 Technicon Research A.G. Detection and/or identification of microorganisms in a test sample using bioluminescence or other exogenous genetically-introduced marker
US5196318A (en) * 1990-06-26 1993-03-23 The Texas A&M University System Precisely regulated expression of deleterious genes

Also Published As

Publication number Publication date
DK0580692T3 (da) 2003-12-08
DE69233160T2 (de) 2004-06-09
GB9108307D0 (en) 1991-06-05
DE69233160D1 (de) 2003-09-18
WO1992018614A1 (en) 1992-10-29
ES2203610T3 (es) 2004-04-16
EP0580692A1 (de) 1994-02-02
JPH06506588A (ja) 1994-07-28
EP0580692B1 (de) 2003-08-13
CA2105395A1 (en) 1992-10-19
US5593827A (en) 1997-01-14

Similar Documents

Publication Publication Date Title
DK0580692T3 (da) Autoinducer
FI921030A (fi) Cykliska ureaderivat, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning
ES2117795T3 (es) Derivados de acetamida y su uso como modificadores del comportamiento de toma alimentaria.
ES8705400A1 (es) Un procedimiento para la preparacion de nuevos derivados de fenoxialquilaminopirimidina.
ES2111188T3 (es) Agentes antibacterianos derivados de feniloxazolidinona sustituida con tropona.
NO20025725D0 (no) Forbindelse, farmasöytisk preparat inneholdende den samme samt anvendelse derav
SE8001099L (sv) Beta-laktamforeningar
ATE206409T1 (de) N-(1-alkyl-5-phenyl-2,3,4,5-tetrahydro-1-h- benzo(b)(1,5)-diazepin-3-yl)-acetamide
FR2662441B1 (fr) Procede de preparation enantioselective de derives de la phenylisoserine.
HUP0003484A2 (hu) Pirrolidin-3-karbonsav-származékok és alkalmazásuk endotelin antagonistaként
ATE205505T1 (de) Basische oxazolinamid-derivate von ge2270 und ge2270-änlichen antibiotika
DE59308336D1 (de) Antiretrovirale Acyl-Verbindungen
ES458557A1 (es) Un procedimiento de preparacion de derivados de quinazolina.
MX9301361A (es) Derivados de carbapenema antimicrobianos y su preparacion.
ES2093980T3 (es) Proceso de reduccion asimetrica, enzimatica, para producir derivados de 4h-tieno(2,3-6)tiopirano.
MY111439A (en) Thymosin alpha 1 derivatives
ES2140393T3 (es) Compuestos de penem.
ID21677A (id) Proses pembuatan n-[2-(dimetilamino)etil]-akridin-4-karboksamida
FI872532A (fi) Mikrobicida lantbrukskemiska kompositioner.
ES8106147A1 (es) Procedimiento para preparar un 1,2,4-triazol-3-tiol
FI943644A0 (fi) Uudet happoanhydridit, niiden valmistus ja käyttö
BG101996A (en) 9-n-ethylenederivatives of 9(s)-erythromycylamine
AU8915582A (en) N-(3-trimethylstannylalkylene)-n:-phenylsulfonyl and n:-benzoyl-ureas

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0580692

Country of ref document: EP

REN Ceased due to non-payment of the annual fee